Previous 10 | Next 10 |
CANTON, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, toda...
Organogenesis Holdings, Inc. (ORGO) Q2 2020 Earnings Conference Call August 10, 2020 17:00 ET Company Participants Gary Gillheeney - President, Chief Executive Officer & Director Timothy Cunningham - Chief Financial Officer Conference Call Participants Matthew Miksic - Cr...
Image source: The Motley Fool. Organogenesis Holdings Inc (NASDAQ: ORGO) Q2 2020 Earnings Call Aug 10, 2020 , 5:00 p.m. ET Operator Continue reading
Organogenesis Holdings (NASDAQ: ORGO ) : Q2 GAAP EPS of -$0.05 beats by $0.18 . More news on: Organogenesis Holdings Inc., Earnings news and commentary, Read more ...
CANTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
CANTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets,...
China Finance Online (NASDAQ: JRJC ) +148% on agreement with Dow Jones. More news on: China Finance Online Co. Limited, Capitala Finance Corp, Immutep Limited, Stocks on the move, , Read more ...
Organogenesis Holdings (NASDAQ: ORGO ) expects Q2 net revenue between $68M - $68.6M (+5% - +6% Y/Y) vs. consensus of $48.25M and net revenue from PuraPly products between $27.7M - $28.1M, down 5% to 7% Y/Y. More news on: Organogenesis Holdings Inc., Healthcare stocks news, Stocks on the ...
CANTON, Mass., July 15, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
Quick Take ACell ( ACLL ) has filed to raise $75 million from the sale of its common stock, according to an amended registration statement . The company develops and sells wound treatment systems for various tissue care applications. ACLL was growing revenue sharply but has since felt t...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...